Ruth T. Yu
20Patents
4h-index
17Co-inventors
56Inventor score
Filing activity: Dec 29, 2008 → Jul 19, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9546379B2 | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | Chemistry; Metallurgy | 6 | Active |
| US9925241B2 | Mutated fibroblast growth factor (FGF) 1 and methods of use | Chemistry; Metallurgy | 5 | Active |
| US10920199B2 | Reprogramming progenitor compositions and methods of use therefore | Chemistry; Metallurgy | 4 | Active |
| US10912800B2 | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | Chemistry; Metallurgy | 4 | Active |
| US10301268B2 | Analogs of fexaramine and methods of making and using | Chemistry; Metallurgy | 2 | Active |
| US8962546B2 | Modulation of estrogen receptor-related receptor gamma (ERRγ) and uses therefor | Human Necessities | 1 | Active |
| US9192601B2 | Methods for enhancing muscle performance and tone | Chemistry; Metallurgy | 1 | Active |
| US11376264B2 | Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatment | Human Necessities | 1 | Active |
| US10539572B2 | Compositions and methods for treating age-related diabetes and related disorders | Physics | 1 | Active |
| US10695404B2 | Treatment of steroid-induced hyperglycemia with fibroblast growth factor (FGF) 1 analogs | Chemistry; Metallurgy | 1 | Active |
| US11981931B2 | Reprogramming progenitor compositions and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11428697B2 | Compositions and methods for treating age-related diabetes and related disorders | Physics | 0 | Active |
| US11440889B2 | Analogs of fexaramine and methods of making and using | Chemistry; Metallurgy | 0 | Active |
| US11760977B2 | Compositions and methods for organoid generation and disease modeling | Physics | 0 | Active |
| US10450277B2 | Analogs of fexaramine and methods of making and using | Chemistry; Metallurgy | 0 | Active |
| US12213999B2 | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | Chemistry; Metallurgy | 0 | Active |
| US10815203B2 | Analogs of fexaramine and methods of making and using | Chemistry; Metallurgy | 0 | Active |
| US11542309B2 | Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose | Human Necessities | 0 | Active |
| US12253527B2 | Compositions and methods for treating age-related diabetes and related disorders | Physics | 0 | Active |
| US11685901B2 | Compositions and methods for organoid generation and disease modeling | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.